Vertebrobasilar Disease
NEJM 352:2618-2626, Savitz,S.I.&Caplan,L.R., 2005
High-Density Lipoprotein Cholesterol and Ischemic Stroke in the Elderly
JAMA 285:2729-2735, Sacco,R.L.,et al, 2001
Barriers to Acute Stroke Therapy and Stroke Prevention in Mexican Americans
Stroke 32:1360-1364, Morgenstern,L.B.,et al, 2001
Treatment with Tissue Plasminogen Activator and Inpatient Mortality Rates for Patients with Ischemic Stroke Treated in Community Hospitals
Stroke 32:1832-1839,1840, Reed,S.D.,et al, 2001
The Efficacy & Safety of Ticlopidine & Aspirin in Non-Whites:Subgroup from Ticlopidine Aspirin Stroke Study
Neurol 43:27-31, Weisberg,L.A., 1993
Prevalence and Determinants of Subclinical Brain Infarction: The Northern Manhattan Study
Neurol 70:425-430,416, Prabhakaran,S.,et al, 2008
Stroke in the Young in the Northern Manhattan Stroke Study
Stroke 33:2789-2793, Jacobs,B.S.,et al, 2002
Differences in Stroke Between White, Hispanic & Native American Patients, Barrow Neuro Inst Stroke Database
Stroke 29:29-33, 21998., Frey,J.L.,et al, 1998
Illicit Drug-Associated Ischemic Stroke in the Baltimore-Washington Young Stroke Study
Neurol 50:1688-1693, Sloan,M.A.,et al, 1998
Clinical Features of Moyamoya Disease in the United States
Stroke 29:1347-1351, Chiu,D.,et al, 1998
Cerebrovascular Disease in African Americans
Stroke 29:2656-2664, Gorelick,P. B., 1998